Thursday, November 20, 2008

Chemo in a Pill?

New research on cancer treatment may mean an easier way for lung cancer patients to take chemotherapy treatments.  

The Lancet medical journal released an international study that showed patients on the drug, Iressa, survived about as long as those on another course of chemotherapy.

Iressa is a more expensive and newer treatment, but its maker, AstraZeneca, says the pill attacks specific growth receptors on cancer cells, which means less side effects for patients. 

The most common side effects of Iressa include rash, acne and diarrhea.  Patients on chemotherapy typically dealt with fatigue, a higher risk of infections, as well as hair loss.

Iressa is currently sold in the U.S. and is approved for patients who did not show improvement while on chemotherapy.  Also, researchers have found that the drug works better in non-smoking patients, Asians, women and those with a "certain genetic profile."

No comments: